Episode Details

Mighty Trial: A New Hope for Rare, Aggressive Childhood Cancers - A groundbreaking CAR T-cell therapy trial, Mighty, is offering fresh hope to kids and young adults battling rare, aggressive solid tumors. Led by UCL experts, the trial targets three tough cancers: rhabdomyosarcoma, Ewing sarcoma, and soft tissue sarcoma. The trial, which includes up to sixty patients from the UK and US, aims to provide a tailored immune boost that spares healthy cells while wiping out cancer. Recruitment is underway at top hospitals, backed by Cancer Research UK and the US National Cancer Institute.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/601d37ccf6d70046